Myriad Genetics, Inc. (MYGN)
6.63
+0.11
(+1.69%)
USD |
NASDAQ |
Jan 07, 16:00
6.605
-0.02
(-0.38%)
After-Hours: 20:00
Myriad Genetics Research and Development Expense (Quarterly): 28.20M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Insulet Corp. | 77.20M |
| Neogen Corp. | 5.125M |
| ICU Medical, Inc. | 21.25M |
| Intuitive Surgical, Inc. | 329.40M |
| Repligen Corp. | 14.18M |